{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:52:41Z","timestamp":1788382361500,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40801-022-00301-x","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T16:05:41Z","timestamp":1654272341000},"page":"321-331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-3884","authenticated-orcid":false,"given":"Corine","family":"Rollema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-7535","authenticated-orcid":false,"given":"Eric N.","family":"van Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-0467","authenticated-orcid":false,"given":"Corine","family":"Ekhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-3224","authenticated-orcid":false,"given":"Florence P. A. M.","family":"van Hunsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-1719","authenticated-orcid":false,"given":"Tjalling W.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"issue":"9","key":"301_CR1","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/all.12235","volume":"68","author":"G Roberts","year":"2013","unstructured":"Roberts G, Xatzipsalti M, Borrego LM, Custovicm A, Halken S, Hellings PW, et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68(9):1102\u201316. https:\/\/doi.org\/10.1111\/all.12235.","journal-title":"Allergy"},{"issue":"1","key":"301_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1398-9995.2008.01884.x","volume":"64","author":"N A\u00eft-Khaled","year":"2009","unstructured":"A\u00eft-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123\u201348. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01884.x.","journal-title":"Allergy"},{"issue":"10","key":"301_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1398-9995.2008.01824.x","volume":"63","author":"PJ Bousquet","year":"2008","unstructured":"Bousquet PJ, Leynaert B, Neukirch F, Sunyer J, Janson CM, Anto J, Jarvis D, Burney P. Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I. Allergy. 2008;63(10):1301\u20139. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01824.x.","journal-title":"Allergy"},{"issue":"10","key":"301_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fphar.2019.00294","volume":"29","author":"AM Watts","year":"2019","unstructured":"Watts AM, Cripps AW, West NP, Cox AJ. Modulation of allergic inflammation in the nasal mucosa of allergic rhinitis sufferers with topical pharmaceutical agents. Front Pharmacol. 2019;29(10):294. https:\/\/doi.org\/10.3389\/fphar.2019.00294.","journal-title":"Front Pharmacol"},{"key":"301_CR5","doi-asserted-by":"publisher","unstructured":"Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl.):S1\u201384. https:\/\/doi.org\/10.1016\/j.jaci.2008.06.003. Erratum in: J Allergy Clin Immunol. 2008;122(6):1237.","DOI":"10.1016\/j.jaci.2008.06.003"},{"key":"301_CR6","unstructured":"European Commission. A guideline on summary of product characteristics (SmPC). Available: \nhttps:\/\/ec.europa.eu\/health\/system\/files\/2016-11\/smpc_guideline_rev2_en_0.pdf. 2009. Accessed 21 June 2021."},{"issue":"6","key":"301_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/00002018-200022060-00001.Erratum.In:DrugSaf2000Aug;23(2):99","volume":"22","author":"RH Meyboom","year":"2000","unstructured":"Meyboom RH, Lindquist M, Egberts AC. An ABC of drug-related problems. Drug Saf. 2000;22(6):415\u201323. https:\/\/doi.org\/10.2165\/00002018-200022060-00001.Erratum.In:DrugSaf2000Aug;23(2):99.","journal-title":"Drug Saf"},{"issue":"6","key":"301_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.otohns.2003.10.001","volume":"129","author":"MS Benninger","year":"2003","unstructured":"Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surg. 2003;129(6):739\u201350. https:\/\/doi.org\/10.1016\/j.otohns.2003.10.001.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"301_CR9","first-page":"956","volume":"48","author":"CL Smith","year":"1998","unstructured":"Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung. 1998;48(9):956\u201360.","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"301_CR10","first-page":"1","volume":"22","author":"J Sastre","year":"2012","unstructured":"Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol. 2012;22(1):1\u201312.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4 Pt 1","key":"301_CR11","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/s0091-6749(99)70310-6","volume":"104","author":"J Corren","year":"1999","unstructured":"Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol. 1999;104(4 Pt 1):S144\u20139. https:\/\/doi.org\/10.1016\/s0091-6749(99)70310-6.","journal-title":"J Allergy Clin Immunol"},{"issue":"7456","key":"301_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/bmj.329.7456.44","volume":"329","author":"BH Stricker","year":"2004","unstructured":"Stricker BH, Psaty BM. Detection, verification, and quantification of adverse drug reactions. BMJ. 2004;329(7456):44\u20137. https:\/\/doi.org\/10.1136\/bmj.329.7456.44.","journal-title":"BMJ"},{"issue":"2","key":"301_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109\u201317. https:\/\/doi.org\/10.2165\/00002018-199920020-00002.","journal-title":"Drug Saf"},{"key":"301_CR14","unstructured":"KNMP. Apothekersorganisatie. The G-Standaard: the medicines standard in healthcare. Available:  \nhttps:\/\/www.knmp.nl\/over-de-knmp\/producten-en-diensten\/g-standaard-medicines-standard-healthcare.\nLast update: March 29th, 2022.\nAccessed 2 July 2021."},{"issue":"8","key":"301_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13(8):519\u201323. https:\/\/doi.org\/10.1002\/pds.1001.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"301_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/pds.4364","volume":"27","author":"JHG Scholl","year":"2018","unstructured":"Scholl JHG, van Hunsel FPAM, Hak E, van Puijenbroek EP. A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands. Pharmacoepidemiol Drug Saf. 2018;27(2):199\u2013205. https:\/\/doi.org\/10.1002\/pds.4364.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"301_CR17","unstructured":"European Medicines Agency. Clinical safety data management: definitions and standards for expedited reporting. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002749.pdf. Accessed 12 Apr 2022."},{"issue":"2","key":"301_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"301_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1017\/S0022215117002080","volume":"131","author":"V Ganesh","year":"2017","unstructured":"Ganesh V, Banigo A, McMurran AEL, Shakeel M, Ram B. Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey. J Laryngol Otol. 2017;131(11):991\u20136. https:\/\/doi.org\/10.1017\/S0022215117002080.","journal-title":"J Laryngol Otol"},{"key":"301_CR20","unstructured":"Tabassom A, Cho JJ. Epistaxis [updated 2020 Aug 8]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK435997\/. Accessed 12 Apr 2022."},{"issue":"2","key":"301_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12325-018-0665-5","volume":"35","author":"CS Muganurmath","year":"2018","unstructured":"Muganurmath CS, Curry AL, Schindzielorz AH. Causality assessment of olfactory and gustatory dysfunction associated with intranasal fluticasone propionate: application of the Bradford Hill criteria. Adv Ther. 2018;35(2):173\u201390. https:\/\/doi.org\/10.1007\/s12325-018-0665-5.","journal-title":"Adv Ther"},{"issue":"10","key":"301_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2165\/11593120-000000000-00000","volume":"34","author":"M Tuccori","year":"2011","unstructured":"Tuccori M, Lapi F, Testi A, Ruggiero E, Moretti U, Vannacci A, et al. Drug-induced taste and smell alterations: a case\/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting. Drug Saf. 2011;34(10):849\u201359. https:\/\/doi.org\/10.2165\/11593120-000000000-00000.","journal-title":"Drug Saf"},{"issue":"4","key":"301_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/IJG.0000000000001164","volume":"28","author":"A Mohd Zain","year":"2019","unstructured":"Mohd Zain A, Md Noh UK, Hussein S, Che Hamzah J, Mohd Khialdin S, Md DN. The relationship between long-term use of intranasal corticosteroid and intraocular pressure. J Glaucoma. 2019;28(4):321\u20134. https:\/\/doi.org\/10.1097\/IJG.0000000000001164.","journal-title":"J Glaucoma"},{"issue":"4","key":"301_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.survophthal.2020.01.002","volume":"65","author":"G Roberti","year":"2020","unstructured":"Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, Mastropasqua L, et al. Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management. Surv Ophthalmol. 2020;65(4):458\u201372. https:\/\/doi.org\/10.1016\/j.survophthal.2020.01.002.","journal-title":"Surv Ophthalmol."},{"issue":"5","key":"301_CR25","first-page":"151","volume":"78","author":"AS Nakatsuka","year":"2019","unstructured":"Nakatsuka AS, Khanamiri HN, Lam QN, El-Annan J. Intranasal corticosteroids and central serous chorioretinopathy: a report and review of the literature. Hawaii J Med Public Health. 2019;78(5):151\u20134.","journal-title":"Hawaii J Med Public Health."},{"issue":"5","key":"301_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/jop.2006.0067","volume":"23","author":"ER James","year":"2007","unstructured":"James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007;23(5):403\u201320. https:\/\/doi.org\/10.1089\/jop.2006.0067.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"301_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/lary.27209","volume":"129","author":"CV Valenzuela","year":"2019","unstructured":"Valenzuela CV, Liu JC, Vila PM, Simon L, Doering M, Lieu JEC. Intranasal corticosteroids do not lead to ocular changes: a systematic review and meta-analysis. Laryngoscope. 2019;129(1):6\u201312. https:\/\/doi.org\/10.1002\/lary.27209.","journal-title":"Laryngoscope"},{"issue":"6","key":"301_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/0194599820931455","volume":"163","author":"AM Donaldson","year":"2020","unstructured":"Donaldson AM, Choby G, Kim DH, Marks LA, Lal D. Intranasal corticosteroid therapy: systematic review and meta-analysis of reported safety and adverse effects in adults. Otolaryngol Head Neck Surg. 2020;163(6):1097\u2013108. https:\/\/doi.org\/10.1177\/0194599820931455.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"301_CR29","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1177\/0194599820931454","volume":"163","author":"AM Donaldson","year":"2020","unstructured":"Donaldson AM, Choby G, Kim DH, Marks LA, Lal D. Intranasal corticosteroid therapy: systematic review and meta-analysis of reported safety and adverse effects in children. Otolaryngol Head Neck Surg. 2020;163(6):1087\u201396. https:\/\/doi.org\/10.1177\/0194599820931454.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"301_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04980.x","volume":"1179","author":"OM Wolkowitz","year":"2009","unstructured":"Wolkowitz OM, Burke H, Epel ES, Reus VI. Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci. 2009;1179:19\u201340. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04980.x.","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"301_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1081-1206(10)60837-X","volume":"101","author":"J Pokladnikova","year":"2008","unstructured":"Pokladnikova J, Meyboom RH, Vlcek J, Edwards RI. Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of the international pharmacovigilance programme of the World Health Organization. Ann Allergy Asthma Immunol. 2008;101(1):67\u201373. https:\/\/doi.org\/10.1016\/S1081-1206(10)60837-X.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"301_CR32","doi-asserted-by":"publisher","unstructured":"de Vries TW, de Langen-Wouterse JJ, van Puijenbroek E, Duiverman EJ, de Jong-Van den Berg LT. Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands. Eur J Clin Pharmacol. 2006;62(5):343\u20136. https:\/\/doi.org\/10.1007\/s00228-006-0102-6.","DOI":"10.1007\/s00228-006-0102-6"},{"issue":"8","key":"301_CR33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/archdischild-2019-317933","volume":"105","author":"C Ekhart","year":"2020","unstructured":"Ekhart C, Vries T, Hunsel FV. Psychiatric adverse drug reactions in the paediatric population. Arch Dis Child. 2020;105(8):749\u201355. https:\/\/doi.org\/10.1136\/archdischild-2019-317933.","journal-title":"Arch Dis Child"},{"issue":"6","key":"301_CR34","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1651-2227.2008.00770.x","volume":"97","author":"TW de Vries","year":"2008","unstructured":"de Vries TW, van Roon EN, Duiverman EJ. Inhaled corticosteroids do not affect behaviour. Acta Paediatr. 2008;97(6):786\u20139. https:\/\/doi.org\/10.1111\/j.1651-2227.2008.00770.x.","journal-title":"Acta Paediatr"},{"issue":"11","key":"301_CR35","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1651-2227.2012.02805.x","volume":"101","author":"W Quak","year":"2012","unstructured":"Quak W, Klok T, Kaptein AA, Duiverman EJ, Brand PL. Preschool children with high adherence to inhaled corticosteroids for asthma do not show behavioural problems. Acta Paediatr. 2012;101(11):1156\u201360. https:\/\/doi.org\/10.1111\/j.1651-2227.2012.02805.x.","journal-title":"Acta Paediatr"},{"issue":"3","key":"301_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-2982.2008.01724.x","volume":"29","author":"J Pokladnikova","year":"2009","unstructured":"Pokladnikova J, Meyboom RH, Vlcek J, Edwards RI. Can intranasal corticosteroids cause migraine-like headache? Cephalalgia. 2009;29(3):360\u20134. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01724.x.","journal-title":"Cephalalgia"},{"issue":"5","key":"301_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1468-2982.2001.00196.x","volume":"21","author":"RH Kemper","year":"2001","unstructured":"Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia. 2001;21(5):549\u201357. https:\/\/doi.org\/10.1046\/j.1468-2982.2001.00196.x.","journal-title":"Cephalalgia"},{"key":"301_CR38","unstructured":"Lareb. Signal on fluticasone (both inhaled and nasal) and palpitations. 2014. https:\/\/databankws.lareb.nl\/Downloads\/KWB_2014_4_flut.pdf. Accessed 12 Apr 2022."},{"issue":"8","key":"301_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028511","volume":"9","author":"RM Fernandes","year":"2019","unstructured":"Fernandes RM, Wingert A, Vandermeer B, Featherstone R, Ali S, Plint AC, et al. Safety of corticosteroids in young children with acute respiratory conditions: a systematic review and meta-analysis. BMJ Open. 2019;9(8): e028511. https:\/\/doi.org\/10.1136\/bmjopen-2018-028511.","journal-title":"BMJ Open"},{"issue":"5","key":"301_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/1715163515597451","volume":"148","author":"J Stroeder","year":"2015","unstructured":"Stroeder J, Evans C, Mansell H. Corticosteroid-induced bradycardia: case report and review of the literature. Can Pharm J (Ott). 2015;148(5):235\u201340. https:\/\/doi.org\/10.1177\/1715163515597451.","journal-title":"Can Pharm J (Ott)."},{"issue":"3","key":"301_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3109\/03009748609092597","volume":"15","author":"N Tvede","year":"1986","unstructured":"Tvede N, Nielsen LP, Andersen V. Bradycardia after high-dose intravenous methylprednisolone therapy. Scand J Rheumatol. 1986;15(3):302\u20134. https:\/\/doi.org\/10.3109\/03009748609092597.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"301_CR42","first-page":"47","volume":"5","author":"A Al Shibli","year":"2012","unstructured":"Al Shibli A, Al Attrach I, Hamdan MA. Bradycardia following oral corticosteroid use: case report and literature review. Arab J Nephrol Transplant. 2012;5(1):47\u20139.","journal-title":"Arab J Nephrol Transplant."},{"issue":"10","key":"301_CR43","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1177\/1060028020908067","volume":"54","author":"J Li","year":"2020","unstructured":"Li J, Ding L. Effectiveness of steroid treatment for sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Ann Pharmacother. 2020;54(10):949\u201357. https:\/\/doi.org\/10.1177\/1060028020908067.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"301_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/archotol.127.3.253","volume":"127","author":"C Alexiou","year":"2001","unstructured":"Alexiou C, Arnold W, Fauser C, Schratzenstaller B, Gloddek B, Fuhrmann S, et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg. 2001;127(3):253\u20138. https:\/\/doi.org\/10.1001\/archotol.127.3.253.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"11","key":"301_CR45","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1177\/00034894211007222","volume":"130","author":"S Ahsanuddin","year":"2021","unstructured":"Ahsanuddin S, Povolotskiy R, Tayyab R, Nasser W, Barinsky GL, Grube JG, et al. Adverse events associated with intranasal sprays: an analysis of the Food and Drug Administration database and literature review. Ann Otol Rhinol Laryngol. 2021;130(11):1292\u2013301. https:\/\/doi.org\/10.1177\/00034894211007222.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1 Suppl.","key":"301_CR46","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1067\/mai.2001.115564","volume":"108","author":"AL Boner","year":"2001","unstructured":"Boner AL. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children. J Allergy Clin Immunol. 2001;108(1 Suppl.):S32\u20139. https:\/\/doi.org\/10.1067\/mai.2001.115564.","journal-title":"J Allergy Clin Immunol"},{"key":"301_CR47","doi-asserted-by":"publisher","unstructured":"Hopkins RL, Leinung MC. Exogenous Cushing\u2019s syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin N Am. 2005;34(2):371\u201384, ix. doi: https:\/\/doi.org\/10.1016\/j.ecl.2005.01.013.","DOI":"10.1016\/j.ecl.2005.01.013"},{"issue":"1","key":"301_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/adc.87.1.45","volume":"87","author":"RJ Perry","year":"2002","unstructured":"Perry RJ, Findlay CA, Donaldson MD. Cushing\u2019s syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child. 2002;87(1):45\u20138. https:\/\/doi.org\/10.1136\/adc.87.1.45.","journal-title":"Arch Dis Child"},{"issue":"17","key":"301_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.11604\/pamj.2014.17.237.3332","volume":"28","author":"IO Oluwayemi","year":"2014","unstructured":"Oluwayemi IO, Oduwole AO, Oyenusi E, Onyiriuka AN, Abdullahi M, Fakeye-Udeogu OB, et al. Iatrogenic Cushing\u2019s syndrome in children following nasal steroid. Pan Afr Med J. 2014;28(17):237. https:\/\/doi.org\/10.11604\/pamj.2014.17.237.3332.","journal-title":"Pan Afr Med J"},{"issue":"3","key":"301_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4274\/jcrpe.726","volume":"4","author":"D Dutta","year":"2012","unstructured":"Dutta D, Shivaprasad KS, Ghosh S, Mukhopadhyay S, Chowdhury S. Iatrogenic Cushing\u2019s syndrome following short-term intranasal steroid use. J Clin Res Pediatr Endocrinol. 2012;4(3):157\u20139. https:\/\/doi.org\/10.4274\/jcrpe.726.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6","key":"301_CR51","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/s0091-6749(94)70043-5","volume":"93","author":"DB Allen","year":"1994","unstructured":"Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol. 1994;93(6):967\u201376. https:\/\/doi.org\/10.1016\/s0091-6749(94)70043-5.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"301_CR52","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1542\/peds.105.2.e22","volume":"105","author":"EJ Schenkel","year":"2000","unstructured":"Schenkel EJ, Skoner DP, Bronsky EA, Miller SD, Pearlman DS, Rooklin A, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000;105(2):E22. https:\/\/doi.org\/10.1542\/peds.105.2.e22.","journal-title":"Pediatrics"},{"issue":"2","key":"301_CR53","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1542\/peds.105.2.e23","volume":"105","author":"DP Skoner","year":"2000","unstructured":"Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics. 2000;105(2):E23. https:\/\/doi.org\/10.1542\/peds.105.2.e23.","journal-title":"Pediatrics"},{"issue":"6","key":"301_CR54","first-page":"407","volume":"23","author":"DB Allen","year":"2002","unstructured":"Allen DB, Meltzer EO, Lemanske RF Jr, Philpot EE, Faris MA, Kral KM, et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002;23(6):407\u201313.","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"301_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/IPRP.S129544","volume":"4","author":"MB Bridgeman","year":"2017","unstructured":"Bridgeman MB. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis. Integr Pharm Res Pract. 2017;4(6):109\u201319. https:\/\/doi.org\/10.2147\/IPRP.S129544.","journal-title":"Integr Pharm Res Pract."},{"issue":"7","key":"301_CR56","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1398-9995.1993.tb01103.x","volume":"48","author":"N Mygind","year":"1993","unstructured":"Mygind N. Glucocorticosteroids and rhinitis. Allergy. 1993;48(7):476\u201390. https:\/\/doi.org\/10.1111\/j.1398-9995.1993.tb01103.x.","journal-title":"Allergy"},{"issue":"12","key":"301_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/JAA.S189523","volume":"3","author":"C Rollema","year":"2019","unstructured":"Rollema C, van Roon EN, de Vries TW. Inadequate quality of administration of intranasal corticosteroid sprays. J Asthma Allergy. 2019;3(12):91\u20134. https:\/\/doi.org\/10.2147\/JAA.S189523.","journal-title":"J Asthma Allergy."}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-022-00301-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T04:18:28Z","timestamp":1660969108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-022-00301-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1007\/s40801-022-00301-x","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"22 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial or non-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Corine Rollema, Eric N. van Roon, Corine Ekhart, Florence P.A.M. van Hunsel and Tjalling W. de Vries have no relevant conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval was necessary for this study because of the retrospective and anonymous study design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets for this article are not publicly available because of the Lareb data protection policy. Requests to access the datasets should be directed to the first author and will be granted on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The\u00a0Structured Query Language statements for the data used in this article are not publicly available because of the Lareb data protection policy. Requests to access the datasets should be directed to the first author and will be granted on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"The original study protocol was designed by all authors. The query and dataset were established by CE. Data analysis was performed by CR; here, ENR, CE, FPAMH and TWV fulfilled an advisory and supervisory role. The design of the manuscript was determined by all authors, and CR developed the design into this article. All authors contributed to the final data analysis and to manuscript drafting and revision. All authors approved the final version to be published and agree to be accountable for all aspects of the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}